RORα inhibits cell proliferation and expression of the E2F1-targeted genes. RORα inhibits cell proliferation and expression of the E2F1-targeted genes.

Slides:

Advertisements

Similar presentations

Supplemental Material for Endothelial CXCR7 Regulates Breast Cancer Metastasis Amanda C. Stacer 1 Joseph Fenner 1 Stephen P. Cavnar 2 Annie Xiao 1 Shuang.

Advertisements

Cell Physiol Biochem 2013;32: DOI: /

Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in.

Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a Cell Physiol Biochem.

Neal et al.Supplementary Figure S1

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.

Cell Physiol Biochem 2013;31: DOI: /

Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.

A. B. Supplemental Figure S2. A. Cell cycle G1/S Growth Factor Regulation. Publically available data from (20;

Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing.

Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova, Yuling Wang, Felipe.

Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT Zhen-Yu He, San-Gang Wu, Fang Peng,

Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and.

Sarah A. Best, Amy N. Nwaobasi, Chrysalyne D. Schmults, Matthew R

Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC Guanming Jiao, Qi Huang, Muren Hu, Xuchun Liang, Fuchen Li, Chunling.

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.

Cell Physiol Biochem 2016;39: DOI: /

Sarah A. Best, Amy N. Nwaobasi, Chrysalyne D. Schmults, Matthew R

Volume 9, Issue 2, Pages (August 2017)

Volume 18, Issue 2, Pages (August 2010)

Targeted Nanoparticles Deliver siRNA to Melanoma

Supplementary Fig. 1 Co-treatment inhibited Ki67 expression.

Volume 20, Issue 3, Pages (September 2011)

Molecular Therapy - Nucleic Acids

Volume 6, Issue 5, Pages (March 2014)

Effects of SC144 on in vivo ovarian tumor.

Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.

(A) Schematic representation of the conditional Lats1 locus.

Volume 141, Issue 6, Pages e5 (December 2011)

Volume 25, Issue 3, Pages (March 2017)

Volume 10, Issue 1, Pages (January 2018)

Brian Poligone, Elaine S. Gilmore, Carolina V

Volume 7, Issue 2, Pages (February 2003)

Znf217 overexpression promotes increased cell motility and aberrant epithelial marker expression. Znf217 overexpression promotes increased cell motility.

miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK

Molecular Therapy - Nucleic Acids

Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.

Figure 1. RSPO3 expression is upregulated in bladder cancer

Volume 17, Issue 2, Pages (February 2009)

Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang Molecular.

Xuepei Lei, Jianwei Jiao Stem Cell Reports

Volume 6, Issue 3, Pages (September 2002)

Volume 167, Issue 2, Pages e9 (October 2016)

Ectopic expression of caveolin-1 in ZR75 human breast cancer cells downregulated survivin and decreased cell proliferation. Ectopic expression of caveolin-1.

CYP1A1 knockdown increases cell death.

Volume 4, Issue 4, Pages (April 2015)

Fig. 6 RUNX/CBFB interaction inhibitor, Ro5-3335, significantly decreases mouse neurofibroma growth in vivo. RUNX/CBFB interaction inhibitor, Ro5-3335,

Figure 4. Effects of chloride channel-3 (ClC-3) knockdown on the expression of cell cycle-regulatory proteins. (A) Representative western blot images of.

Figure 6. Effects of chloride channel-3 (ClC-3) knockdown on the growth of human breast tumors in vivo. (A) Representative images of tumors on day 20 from.

Effects of knockdown of DDR1 levels on proliferation and apoptosis.

Effects of knockdown of ANRIL on NSCLC cell cycle and apoptosis in vitro. Effects of knockdown of ANRIL on NSCLC cell cycle and apoptosis in vitro. A,

PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant p53 in vivo. PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant.

Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. A.

ONC201 activates an ISR, decreases cyclin D1 expression, and causes an accumulation of cells in G1 in TNBC cells sensitive to the compounds' antiproliferative.

Overexpression of DDB2 reduces invasive abilities in lungs of aggressive breast tumor cells. Overexpression of DDB2 reduces invasive abilities in lungs.

RNF2 promotes TGFβ signaling.

Paclitaxel treatment along with CXCR2 knockdown reduces tumor growth and metastasis. Paclitaxel treatment along with CXCR2 knockdown reduces tumor growth.

Volume 23, Issue 4, Pages (April 2015)

Cell lines with aberrant expression of NRG1 are exquisitely sensitive to downregulation of ERBB3 signaling. Cell lines with aberrant expression of NRG1.

miR-100 suppresses bladder cancer cell growth in vitro and in vivo.

The effects of HDAC2 knockdown on cell-cycle proteins.

Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.

Loss of HDAC3 inhibits CREBBP-mutant lymphoma growth in vitro and in vivo. Loss of HDAC3 inhibits CREBBP-mutant lymphoma growth in vitro and in vivo. A,

Effect of SPINDLIN1 protein on cancer cell proliferation and invasion.

AR inhibition decreases ER+/AR+ breast cancer growth.

Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.

Fig. 6 The combined therapeutic efficacy of N-pepABS and low dose of Dox on MDA-MB-231 xenografts. The combined therapeutic efficacy of N-pepABS and low.

PARP1 suppresses the transcription of PD-L1 in cancer cells.

miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.

Molecular Therapy - Nucleic Acids

Presentation transcript:

RORα inhibits cell proliferation and expression of the E2F1-targeted genes. RORα inhibits cell proliferation and expression of the E2F1-targeted genes. (A) RORα expression was assessed by Western blotting in breast cancer cells infected with lentivirus containing the RORα-expressing construct. (B) Cell proliferation in control and RORα-expressing breast cancer cells was analyzed by EdU staining. Cells were cultured in 3D Matrigel. RORα expression inhibited cell proliferation in MDA-MB 157 and MDA-MB 231 cells (n = 3; *, P < 0.05; **, P < 0.01). (C) Control or RORα-expressing T4 cells or MDA-MB 231 cells were injected into the mammary fat pad in SCID mice. Restoring RORα expression in T4 cells or MDA-MB 231 cells inhibited tumor growth (n = 6; *, P < 0.05; **, P < 0.01). (D) Cell proliferation was examined by Ki67 staining in tumors formed by control or RORα-expressing T4-2 and MDA-MB 231 cells. The bar graph shows the Ki67 positivity ratio (n = 3; **, P < 0.01). (E) Gene set enrichment analysis (GSEA) identified the gene set “CELL CYCLE_KEGG” to be enriched among genes that show a reduced expression in RORα-expressing cells (P = 0.094). (F) GSEA analysis showed that the gene set “E2F1_Q6_01” had reduced expression in RORα-expressing breast cancer cells. (G) Heat map showing that E2F1 target genes were downregulated in RORα-expressing breast cancer cells compared with control cells. (H) Cell cycle progression in control and RORα-expressing cells was examined by flow cytometry analysis. The percentage of cells in G1 phase was significantly increased, while that of cells in S phase was significantly decreased in RORα-expressing MDA-MB 231 cells (n = 3; *, P < 0.05). (I) The top portion shows silencing efficiency of shRORα in S1 cells, examined by Western blotting. The bottom portion shows cell proliferation in control and shRORα-expressing S1 cells, analyzed by EdU staining. Cells were cultured in 3D Matrigel. Knockdown of RORα expression increased cell proliferation in S1 cells (n = 2; *, P < 0.05). (J) Cell cycle progression was analyzed by flow cytometry in control and RORα-silenced S1 cells. The percentage of cells in G1 phase was significantly decreased, while the percentages of cells in S phase and G2 phase were significantly increased in RORα-silenced cells compared with control cells (n = 3; *, P < 0.05). Gaofeng Xiong, and Ren Xu Mol. Cell. Biol. 2014;34:3066-3075